Am J Health-Syst Pharm
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Order Full text via Infotrieve
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cronk, J.
Right arrow Articles by Moore, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cronk, J.
Right arrow Articles by Moore, W.
American Journal of Hospital Pharmacy, Vol 32, Issue 1, 46-48
Copyright © 1975 by American Society of Health-System Pharmacists

Articles

The pharmacist's ability to use bioavailability data

JD Cronk, RB Williams, and WE Moore


The ability of the pharmacist to use analytical, dissolution, blood level, excretion and cost data in evaluating drug products was studied. A questionnaire asked respondents to evaluate four brands of an antibiotic based on the comparative data presented. The responses of 19 pharmacists were compared to those of an expert panel. The pharmacists performed adequately in evaluating all types of data except urinary excretion data.
 





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1975 by the American Society of Health-System Pharmacists.